European Market Report for Lancet and Lancing Devices 2016 - MedCore
The value of the lancet and lancing device increased in 2015 and modest growth is expected to continue over the forecast period, driven by increasing unit sales and limited by ASP erosion. Unit sales growth will be driven by the increasing patient population and as a result, increasing number of diabetics that are testing their blood glucose levels. However, unit sales growth will be moderated by the continuing trend of manufacturers giving away complimentary lancet and lancing devices to patients, as well as lancet reuse among the diabetic population. ASP erosion will also be driven by the existence of complimentary devices and by the growth of low-price competitors in the lancet and lacing device market. Typically, lancets are sold in packs of 100 or 200, but some are sold in packs of 25, 102, 204 and other combinations. For this reason, ASP is quoted on a per lancet basis.
A lancet is a small needle with a plastic or rubber coating that fits into the top of a lancing device. Lancing devices are pen-like instruments which are used in conjunction with a lancet to draw blood to be applied to a glucose strip. Many lancets come as a component of blood glucose monitoring kits, and can be adjusted for injection depth. Reusable lancets are not as effective as they are more dull and painful and increase the risk of infection.
- EXECUTIVE SUMMARY
- EUROPEAN MARKET FOR DIABETES MONITORING, TREATMENT AND DRUG DELIVERY
- COMPETITIVE ANALYSIS
- MARKET TRENDS
- MARKET DEVELOPMENTS
- MARKETS INCLUDED
- KEY REPORT UPDATES
- VERSION HISTORY
- RESEARCH METHODOLOGY
- 1.1 RESEARCH SCOPE
- 1.2 IDATA’S 9-STEP METHODOLOGY
- Step 1: Project Initiation & Team Selection
- Step 2: Prepare Data Systems and Perform Secondary Research
- Step 3: Preparation for Interviews & Questionnaire Design
- Step 4: Performing Primary Research
- Step 5: Research Analysis: Establishing Baseline Estimates
- Step 6: Market Forecast and Analysis
- Step 7: Identify Strategic Opportunities
- Step 8: Final Review and Market Release
- Step 9: Customer Feedback and Market Monitoring
- DISEASE OVERVIEW
- 2.1 INTRODUCTION
- 2.1.1 Types of Diabetes
- 2.1.2 Diabetes Complications
- 2.1.3 Risk Factors Associated with Type 1 and Type 2 Diabetes
- 2.1.4 Signs and Symptoms
- 2.1.5 Diabetes Monitoring
- 2.1.6 Treatment
- 2.1.7 Drug Delivery Systems
- COUNTRY PROFILES
- 3.1 INTRODUCTION
- 3.1.1.1 Population
- 3.1.1.2 GDP Per Capita
- 3.1.1.3 Units
- 3.2 GERMANY
- 3.3 FRANCE
- 3.4 UNITED KINGDOM
- 3.5 ITALY
- 3.6 SPAIN
- 3.7 BENELUX
- 3.8 SCANDINAVIA
- 3.9 AUSTRIA
- 3.10 SWITZERLAND
- 3.11 PORTUGAL
- LANCET AND LANCING DEVICE MARKET
- 4.1 INTRODUCTION
- 4.2 MARKET ANALYSIS AND FORECAST
- 4.3 DRIVERS AND LIMITERS
- 4.3.1 Market Drivers
- 4.3.2 Market Limiters
- 4.4 COMPETITIVE MARKET SHARE ANALYSIS
- ABBREVIATIONS
- List of Charts
- Chart 1 1: Diabetes Diagnosis, Treatment and Drug Delivery, Europe, 2012 – 2022
- Chart 1 2: Diabetes Diagnosis, Treatment and Drug Delivery Market Overview, Europe, 2012 & 2022
- Chart 3 1: Country Profile, Germany, 2015
- Chart 3 2: Country Profile, France, 2015
- Chart 3 3: Country Profile, United Kingdom, 2015
- Chart 3 4: Country Profile, Italy, 2015
- Chart 3 5: Country Profile, Spain, 2015
- Chart 3 6: Country Profile, Benelux, 2015
- Chart 3 7: Country Profile, Scandinavia, 2015
- Chart 3 8: Country Profile, Austria, 2015
- Chart 3 9: Country Profile, Switzerland, 2015
- Chart 3 10: Country Profile, Portugal, 2015
- Chart 4 1: Total Lancet and Lancing Device Market, Europe, 2012 – 2022
- Chart 4 2: Leading Competitors, Lancet and Lancing Device Market, Europe, 2015
- List of Figures
- Figure 1 1: Diabetes Diagnosis, Treatment and Drug Delivery Competitor Market Share Ranking by Segment, Europe, 2015 (1 of 2)
- Figure 1 2: Diabetes Diagnosis, Treatment and Drug Delivery Competitor Market Share Ranking by Segment, Europe, 2015 (2 of 2)
- Figure 1 3: Companies Researched in this Report, Europe, 2015
- Figure 1 4: Factors Impacting the Diabetes Diagnosis, Treatment and Drug Delivery Market by Segment, Europe (1 of 2)
- Figure 1 5: Factors Impacting the Diabetes Diagnosis, Treatment and Drug Delivery Market by Segment, Europe (2 of 2)
- Figure 1 6: Recent Events in the Diabetes Diagnosis, Treatment and Drug Delivery Market, Europe, 2012 – 2016
- Figure 2 1: Major Types of Diabetes and Related Pathologies, Europe, 2015
- Figure 2 2: Risk Factors Associated with Type 1 and Type 2 Diabetes, Europe, 2015
- Figure 2 3: Signs and Symptoms Associated with Type 1 and Type 2 Diabetes, Europe, 2015
- Figure 4 1: Total Lancet and Lancing Device Market, Europe, 2012 – 2022 (€ and US$)
- Figure 4 2: Units Sold (Millions) by Country, Total Lancet and Lancing Device Market, Europe, 2012 – 2022
- Figure 4 3: Average Selling Price by Country, Total Lancet and Lancing Device Market, Europe, 2012 – 2022 (€)
- Figure 4 4: Average Selling Price by Country, Total Lancet and Lancing Device Market, Europe, 2012 – 2022 (US$)
- Figure 4 5: Market Value by Country, Total Lancet and Lancing Device Market, Europe, 2012 – 2022 (€M)
- Figure 4 6: Market Value by Country, Total Lancet and Lancing Device Market, Europe, 2012 – 2022 (US$M)
- Figure 4 7: Drivers and Limiters, Lancet and Lancing Device Market, Europe, 2015
- Figure 4 8: Leading Competitors, Lancet and Lancing Device Market, Europe, 2015
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook